A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Status:
Recruiting

Trial end date:
2022-08-29

Target enrollment:

Participant gender:

The purpose of this study is to assess safety of canagliflozin + metformin hydrochloride immediate Release (IR) fixed-dose combination.

Phase 4

Johnson & Johnson Private Limited

Canagliflozin
Metformin